Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 135

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 135
---
 our consolidated balance sheets. (2)    Instruments placed with customers consist of drug-delivery and monitoring systems placed with customers under operating leases.Depreciation expense was $16.9 million and $33.8 million for the three and six months ended June 30, 2025, respectively, as compared to $22.3 million and $44.7 million for the three and six months ended June 30, 2024, respectively. Depreciation expense included in costs of goods sold was $15.4 million and $30.2 million, for the three and six months ended June 30, 2025, respectively, as compared to $19.4 million and $38.8 million for the three and six months ended June 30, 2024, respectively.

Note 15:  Goodwill and Intangible Assets, Net

Goodwill    The following table presents the changes in the carrying amount of our goodwill (in thousands):TotalBalance as of January 1, 2025$1,432,772 Currency translation69,148 Balance as of June 30, 2025$1,501,920 Intangible Assets, Net    Intangible assets, carried at cost less accumulated amortization and amortized on a straight-line basis, were as follows (in thousands):

26

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

 Weighted-Average Amortization Life in YearsJune 30, 2025 CostAccumulatedAmortizationNetPatents10$38,718 $24,148 $14,570 Customer contracts1210,202 7,300 2,902 Non-contractual customer relationships8563,987 273,327 290,660 Trademarks15,425 5,425 — Trade name1518,245 8,967 9,278 Developed technology(1) 10627,611 262,023 365,588 Non-compete39,100 9,100 — Total amortized intangible assets $1,273,288 $590,290 $682,998 Internally developed software(2) $15,011 $15,011 Total intangible assets$1,288,299 $590,290